Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-000830

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LINDAHL RICHARD S Director 2025-02-11 Grant or award · Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X05/ownership.xml…